Medical Mycology

Papers
(The H4-Index of Medical Mycology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis55
S5.1b Antifungal r esistance54
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management54
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India40
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants40
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?39
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis36
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India34
P196 A rare presentation of subcutaneous Entomophthoramycosis33
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival32
P361 Demystifying the NIH grant application process for international investigators32
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain30
Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories29
S1.3c Diversity and hybridization in Malassezia furfur29
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis29
Prevalence of azole-resistant Aspergillus fumigatus and other aspergilli in the environment from Argentina27
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis26
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study26
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex24
A 40-year antifungal susceptibility surveillance of Talaromyces marneffei (1984–2024) at a tertiary hospital in Guangxi, China24
Landscape of in situ cytokine expression, soluble C-type lectin receptors, and vitamin D in patients with recurrent vulvovaginal candidiasis23
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa23
0.085628032684326